NLS Pharmaceutics AG (NLS) is a Swiss biotechnology company focused on the development of innovative drugs for the treatment of neurological and psychiatric disorders. With a primary focus on researching and developing medications for epilepsy and mood disorders, NLS Pharmaceutics aims to address unmet needs in the treatment of these diseases. The company is known for its expertise in pharmacology and neuroscience and for its commitment to innovation and discovering new therapeutic approaches. Shares of NLS Pharmaceutics AG (NLS) could be suitable for investors looking to invest in the biotechnology sector with an emphasis on treating neurological and psychiatric disorders.
Feed
There are no posts to show right now.
We use cookies to improve your experience on our site.
